Advancing Sports Medicine: Whole-Body Photobiomodulation in Professional Soccer Players
Universidade Federal de São Carlos is conducting a new clinical trial to explore the use of Whole-Body Photobiomodulation (PBM) therapy […]
Unapproved Medical Device Entered Into Clinical Trial: FDA Implications
Clinical trials continue to drive innovation, and recently, details emerged about a trial involving a device not yet approved or
FDA Approval Pending: Clinical Trial Featuring Unapproved Medical Device Sparks Interest
A clinical trial involving a medical device that has not yet received approval or clearance from the U.S. Food and
Liquid IV’s RECOVER: Investigating Its Role in Post-Exercise Muscle Recovery – Regulatory Update
A recent clinical trial is set to explore Liquid IV’s RECOVER proprietary post-workout supplement as a potential aid in enhancing
Breakthrough Nanotechnology Device Targets Metastatic Solid Tumors Using Hyperthermia
New Phase Ltd. is introducing a groundbreaking innovation for the treatment of advanced metastatic solid tumors. Known as The Sarah
Innovative Smart Contact Lenses Advance Glaucoma Monitoring Technology
Indiana University, alongside partners National Eye Institute (NEI) and Purdue University, is spearheading a groundbreaking clinical trial investigating the use
Key Updates in Field Safety Notices: Impact on Medical Devices and Compliance
Between 27 and 31 October 2025, several Field Safety Notices (FSNs) were issued, highlighting critical updates for medical device safety
Olympus Updates Laser Bronchoscope Instructions Following Safety Concerns
Olympus Corporation has announced an important voluntary labeling update for bronchoscopes used with laser therapy, argon plasma coagulation, and high-frequency
Nationwide Recall of Mislabelled Potassium Chloride Injection – Critical FDA Update
Clinical professionals, regulatory teams, and healthcare providers should note the recent voluntary nationwide recall of a potassium chloride injection product.
FDA Moves to Halt Sale of Unapproved Fluoride Prescription Drugs for Children
The FDA has taken a significant step to protect children from unapproved ingestible fluoride prescription products. Announced on November 3,